Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation.
Giralt
S A
SA
Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York. Electronic address: GiraltS@mskcc.org.
Mangan
K F
KF
Fox Chase Temple BMT Program, Philadelphia.
Maziarz
R T
RT
Oregon Health and Science University, Portland.
Bubalo
J S
JS
Oregon Health and Science University, Portland.
Beveridge
R
R
Fairfax-Northern Virginia Hematology-Oncology P.C., Fairfax.
Hurd
D D
DD
Wake Forest University School of Medicine, Winston-Salem.
Mendoza
F L
FL
Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York.
Rubenstein
E B
EB
Medical & Scientific Affairs, Eisai Inc., Woodcliff Lake.
DeGroot
T J
TJ
Medical & Scientific Affairs, Eisai Inc., Woodcliff Lake.
Schuster
M W
MW
Hematopoietic Stem Cell Transplantation Program, Stony Brook University, Stony Brook, USA.